SLC5A2 and type 2 diabetes mellitus: In type 2 diabetes, overweight andobesity are usually related conditions, and those patients should be encouragedto losing weight, given its benefits, with SGLT2 inhibitors and GLP-1 receptoragonists prescription depending on clinical situation.